| LSB | LakeShore Biopharma Co Ltd | 0.03 | -99.84% |
| NTBL | Notable Labs Inc Ord | 0.03 | -99.79% |
| TNFA | TNF Pharmaceuticals Inc | 0.05 | -99.71% |
| ENLV | Enlivex Ltd | 0.05 | -99.68% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 0.05 | -99.67% |
| AFMD | Affimed N.V. | 0.06 | -99.62% |
| EPIX | Essa Pharma Inc | 0.08 | -99.50% |
| PBM | Psyence Biomedical Ltd | 0.12 | -99.30% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 0.12 | -99.26% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.13 | -99.20% |
| PPBT | Purple Biotech Ltd | 0.14 | -99.13% |
| ENTO | Entero Therapeutics, Inc. Common Stock | 0.15 | -99.07% |
| ONCT | Oncternal Therapeutics Inc | 0.17 | -98.97% |
| PPCB | Propanc Biopharma Inc | 0.18 | -98.88% |
| PMCB | PharmaCyte Biotech Inc | 0.18 | -98.88% |
| NCNA | NuCana plc | 0.19 | -98.85% |
| AZTR | Azitra Inc | 0.20 | -98.79% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.20 | -98.77% |
| APRE | Aprea Therapeutics Inc | 0.21 | -98.73% |
| CTXR | Citius Pharmaceuticals Inc | 0.24 | -98.56% |
| CMND | Clearmind Medicine Inc | 0.25 | -98.46% |
| GRI | GRI Bio Inc | 0.26 | -98.42% |
| ONCO | Onconetix Inc | 0.27 | -98.39% |
| GLMD | Galmed Pharmaceuticals Ltd | 0.28 | -98.29% |
| VTGN | VistaGen Therapeutics Inc | 0.29 | -98.23% |
| APM | Aptorum Group Limited Class A Ordinary Shares | 0.29 | -98.23% |
| KTTA | Pasithea Therapeutics Corp | 0.29 | -98.22% |
| GNPX | Genprex Inc | 0.30 | -98.16% |
| REVB | Revelation Biosciences Inc | 0.31 | -98.10% |
| MGX | Metagenomi Inc | 0.36 | -97.81% |
| BRNS | Barinthus Biotherapeutics Plc. | 0.38 | -97.71% |
| BOLT | Bolt Biotherapeutics Inc | 0.40 | -97.58% |
| ELAB | PMGC Holdings Inc | 0.40 | -97.57% |
| PLRX | Pliant Therapeutics Inc | 0.41 | -97.52% |
| OGEN | Oragenics Inc | 0.42 | -97.47% |
| TCRX | Tscan Therapeutics Inc | 0.42 | -97.46% |
| VRAX | Virax Biolabs Group Ltd - Class A | 0.42 | -97.44% |
| BBLG | Bone Biologics Corp | 0.47 | -97.15% |
| TIL | Instil Bio Inc | 0.48 | -97.09% |
| LNAI | Lunai Bioworks Inc | 0.48 | -97.08% |
| SEER | Seer Inc - Class A | 0.49 | -97.01% |
| GLPG | Galapagos NV | 0.49 | -97.00% |
| APVO | Aptevo Therapeutics Inc | 0.49 | -97.00% |
| ENGN | enGene Holdings Inc | 0.50 | -96.99% |
| XBIT | XBiotech Inc | 0.52 | -96.82% |
| BCYC | Bicycle Therapeutics Plc | 0.53 | -96.78% |
| VIVS | VivoSim Labs Inc | 0.54 | -96.73% |
| IMA | Ikena Oncology Inc | 0.54 | -96.72% |
| SLRN | Acelyrin Inc | 0.56 | -96.59% |
| CDT | CDT Equity Inc | 0.57 | -96.56% |
| ACET | Adicet Bio Inc | 0.57 | -96.52% |
| INAB | IN8bio Inc | 0.59 | -96.39% |
| DWTX | Virios Therapeutics Inc | 0.60 | -96.38% |
| MBIO | Mustang Bio Inc | 0.60 | -96.36% |
| LITS | Lite Strategy Inc | 0.60 | -96.36% |
| CDIO | Cardio Diagnostics Holdings Inc | 0.60 | -96.34% |
| ACHL | Achilles Therapeutics Plc | 0.61 | -96.29% |
| LENZ | LENZ Therapeutics Inc | 0.63 | -96.19% |
| GRCE | Acasti Pharma Inc | 0.63 | -96.19% |
| BOLD | Boundless Bio Inc | 0.64 | -96.11% |
| MURA | Mural Oncology plc | 0.64 | -96.11% |
| VOR | Vor Biopharma Inc | 0.66 | -96.02% |
| NEUP | Neuphoria Therapeutics Inc | 0.66 | -96.02% |
| CLDI | Calidi Biotherapeutics Inc | 0.66 | -95.98% |
| NKTX | Nkarta Inc | 0.66 | -95.97% |
| ORMP | Oramed Pharmaceuticals Inc | 0.70 | -95.76% |
| HLVX | HilleVax Inc | 0.71 | -95.70% |
| CRIS | Curis Inc | 0.71 | -95.68% |
| TOVX | Theriva Biologics Inc | 0.72 | -95.65% |
| FULC | Fulcrum Therapeutics Inc | 0.72 | -95.65% |
| PHIO | Phio Pharmaceuticals Corp | 0.73 | -95.57% |
| BGMS | Bio Green Med Solution Inc | 0.73 | -95.56% |
| KROS | Keros Therapeutics Inc | 0.73 | -95.56% |
| CELZ | Creative Medical Technology Holdings Inc | 0.73 | -95.56% |
| MTNB | Matinas Biopharma Holdings Inc | 0.74 | -95.50% |
| BLRX | Bioline Rx Ltd | 0.76 | -95.39% |
| CURX | Curanex Pharmaceuticals Inc | 0.76 | -95.37% |
| BIVI | BioVie Inc - Class A | 0.76 | -95.37% |
| ARTL | Artelo Biosciences Inc | 0.76 | -95.37% |
| FBIO | Fortress Biotech Inc | 0.77 | -95.35% |
| HYPD | Eyenovia Inc | 0.78 | -95.30% |
| ATOS | Atossa Therapeutics Inc | 0.79 | -95.19% |
| KPRX | Kiora Pharmaceuticals Inc | 0.80 | -95.17% |
| ATYR | Atyr Pharma Inc | 0.81 | -95.11% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 0.82 | -95.01% |
| DRMA | Dermata Therapeutics Inc | 0.83 | -94.97% |
| XLO | Xilio Therapeutics Inc | 0.84 | -94.91% |
| LPCN | Lipocine Inc | 0.85 | -94.85% |
| ENSC | Ensysce Biosciences Inc | 0.85 | -94.81% |
| ENVB | Enveric Biosciences Inc | 0.86 | -94.76% |
| PMVP | PMV Pharmaceuticals Inc | 0.87 | -94.74% |
| THRD | Third Harmonic Bio Inc | 0.89 | -94.59% |
| RNA | Atrium Therapeutics Inc | 0.91 | -94.47% |
| SAVA | Cassava Sciences Inc. | 0.92 | -94.40% |
| NBP | NovaBridge Biosciences. | 0.92 | -94.39% |
| ADVM | Adverum Biotechnologies Inc | 0.93 | -94.35% |
| XBIO | Xenetic Biosciences Inc | 0.94 | -94.32% |
| IMMP | Immutep Ltd | 0.94 | -94.27% |
| ARCT | Arcturus Therapeutics Holdings Inc | 0.95 | -94.26% |
| ACRV | Acrivon Therapeutics Inc | 0.96 | -94.15% |
| VYNE | VYNE Therapeutics Inc | 0.96 | -94.15% |
| TRDA | Entrada Therapeutics Inc | 0.98 | -94.07% |
| AGIO | Agios Pharmaceuticals Inc | 0.99 | -93.98% |
| QNRX | Quoin Pharmaceuticals Ltd | 0.99 | -93.97% |
| NXTC | Nextcure Inc | 1.00 | -93.92% |
| PRTC | PureTech Health plc American Depositary Shares | 1.00 | -93.90% |
| SILO | SILO Pharma Inc | 1.02 | -93.81% |
| JANX | Janux Therapeutics Inc | 1.02 | -93.80% |
| ACXP | Acurx Pharmaceuticals Inc | 1.02 | -93.79% |
| BDTX | Black Diamond Therapeutics Inc | 1.02 | -93.78% |
| CVAC | CureVac N.V. | 1.03 | -93.76% |
| ERNA | Ernexa Therapeutics Inc | 1.03 | -93.74% |
| CMMB | Chemomab Therapeutics Ltd | 1.04 | -93.68% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | 1.05 | -93.63% |
| MBRX | Moleculin Biotech Inc | 1.05 | -93.61% |
| BNTX | BioNTech SE | 1.07 | -93.48% |
| IBIO | iBio Inc | 1.08 | -93.43% |
| CNTX | Context Therapeutics Inc | 1.08 | -93.41% |
| VYGR | Voyager Therapeutics Inc | 1.10 | -93.33% |
| MTVA | MetaVia Inc | 1.10 | -93.33% |
| IMRN | Immuron Ltd | 1.11 | -93.26% |
| RADX | Radiopharm Theranostics Ltd | 1.13 | -93.14% |
| AKTX | Akari Therapeutics Plc | 1.14 | -93.07% |
| QNCX | Quince Therapeutics Inc | 1.15 | -93.04% |
| IVVD | Invivyd Inc | 1.16 | -92.95% |
| VERU | Veru Inc | 1.18 | -92.84% |
| SPRC | SciSparc Ltd | 1.19 | -92.80% |
| OABI | OmniAb Inc | 1.19 | -92.79% |
| LYEL | Lyell Immunopharma Inc | 1.20 | -92.70% |
| SABS | SAB Biotherapeutics Inc | 1.21 | -92.65% |
| PASG | Passage Bio Inc | 1.21 | -92.63% |
| INVA | Innoviva Inc | 1.22 | -92.58% |
| LGVN | Longeveron Inc - Class A | 1.23 | -92.56% |
| JAGX | Jaguar Health Inc | 1.23 | -92.53% |
| PEPG | PepGen Inc | 1.24 | -92.48% |
| CANF | Can-Fite Biopharma Ltd | 1.26 | -92.37% |
| SRPT | Sarepta Therapeutics Inc | 1.26 | -92.35% |
| TARA | Protara Therapeutics Inc | 1.27 | -92.30% |
| UPB | Upstream Bio Inc | 1.28 | -92.24% |
| VNDA | Vanda Pharmaceuticals Inc | 1.28 | -92.21% |
| CVM | Cel-Sci Corp | 1.29 | -92.16% |
| CLGN | CollPlant Biotechnologies Ltd New | 1.30 | -92.13% |
| INTS | Intensity Therapeutics Inc | 1.32 | -91.99% |
| IMUX | Immunic Inc | 1.32 | -91.97% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 1.33 | -91.95% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 1.33 | -91.91% |
| BCTX | BriaCell Therapeutics Corp - New | 1.34 | -91.85% |
| PLRZ | Polyrizon Ltd | 1.34 | -91.83% |
| FDMT | 4D Molecular Therapeutics Inc | 1.35 | -91.78% |
| HCWB | HCW Biologics Inc | 1.37 | -91.70% |
| KAPA | Kairos Pharma Ltd | 1.37 | -91.68% |
| HOWL | Werewolf Therapeutics Inc | 1.37 | -91.68% |
| ARVN | Arvinas Inc | 1.38 | -91.63% |
| EVMN | Evommune Inc | 1.42 | -91.39% |
| GRDX | Entero Therapeutics Inc | 1.44 | -91.27% |
| PRTA | Prothena Corporation plc | 1.45 | -91.22% |
| IPSC | Century Therapeutics Inc | 1.45 | -91.19% |
| MREO | Mereo Biopharma Group Plc | 1.47 | -91.06% |
| CRMD | CorMedix Inc | 1.49 | -90.93% |
| CLRB | Cellectar Biosciences Inc | 1.51 | -90.80% |
| NAUT | Nautilus Biotechnology Inc | 1.55 | -90.60% |
| SGMT | Sagimet Biosciences Inc - Class A | 1.55 | -90.56% |
| LXEO | Lexeo Therapeutics Inc | 1.57 | -90.49% |
| AARD | Aardvark Therapeutics Inc | 1.57 | -90.44% |
| KLRS | Kalaris Therapeutics Inc | 1.59 | -90.35% |
| PTN | Palatin Technologies Inc | 1.60 | -90.29% |
| KRRO | Korro Bio Inc | 1.60 | -90.29% |
| AVIR | Atea Pharmaceuticals Inc | 1.61 | -90.22% |
| WHWK | Whitehawk Therapeutics Inc | 1.62 | -90.15% |
| IKT | Inhibikase Therapeutics Inc | 1.62 | -90.15% |
| IMRX | Immuneering Corp Class A | 1.64 | -90.06% |
| GNTA | Genenta Science SpA | 1.64 | -90.04% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 1.65 | -90.00% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 1.65 | -89.96% |
| ADIL | Adial Pharmaceuticals Inc | 1.65 | -89.96% |
| KALA | Kala Bio Inc | 1.67 | -89.87% |
| RCKT | Rocket Pharmaceuticals Inc | 1.67 | -89.84% |
| CRBU | Caribou Biosciences Inc | 1.70 | -89.67% |
| SNGX | Soligenix Inc | 1.70 | -89.66% |
| MNOV | Medicinova Inc | 1.71 | -89.65% |
| AVXL | Anavex Life Sciences Corporation | 1.72 | -89.56% |
| IMAB | I-Mab | 1.73 | -89.52% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 1.73 | -89.49% |
| MRKR | Marker Therapeutics Inc | 1.75 | -89.40% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1.76 | -89.31% |
| TNYA | Tenaya Therapeutics Inc | 1.77 | -89.27% |
| MOLN | Molecular Partners AG | 1.77 | -89.23% |
| ALXO | Alx Oncology Holdings Inc | 1.78 | -89.21% |
| CCCC | C4 Therapeutics Inc | 1.80 | -89.08% |
| ADXN | Addex Therapeutics Ltd | 1.81 | -89.02% |
| SVA | Sinovac Biotech Ltd | 1.82 | -88.98% |
| GTBP | GT Biopharma Inc | 1.83 | -88.88% |
| BMRN | Biomarin Pharmaceutical Inc | 1.84 | -88.82% |
| RLYB | Rallybio Corp | 1.85 | -88.79% |
| SPRO | Spero Therapeutics Inc | 1.85 | -88.74% |
| ZNTL | Zentalis Pharmaceuticals Inc | 1.86 | -88.71% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | 1.90 | -88.47% |
| RIGL | Rigel Pharmaceuticals | 1.91 | -88.40% |
| ALT | Altimmune Inc | 1.93 | -88.29% |
| FATE | Fate Therapeutics Inc | 1.94 | -88.23% |
| VIR | Vir Biotechnology Inc | 1.97 | -88.04% |
| FBLG | FibroBiologics Inc | 1.99 | -87.91% |
| TVRD | Cara Therapeutics Inc | 2.00 | -87.87% |
| ASBP | Aspire Biopharma Holdings Inc | 2.02 | -87.74% |
| MCRB | Seres Therapeutics Inc | 2.05 | -87.58% |
| PMN | ProMIS Neurosciences Inc | 2.07 | -87.44% |
| ABOS | Acumen Pharmaceuticals Inc | 2.09 | -87.32% |
| ANTX | AN2 Therapeutics Inc | 2.10 | -87.27% |
| IVA | Inventiva | 2.10 | -87.23% |
| CMPX | Compass Therapeutics Inc | 2.10 | -87.22% |
| ALZN | Alzamend Neuro Inc | 2.11 | -87.21% |
| ARMP | Armata Pharmaceuticals Inc | 2.11 | -87.19% |
| STRO | Sutro Biopharma Inc | 2.11 | -87.18% |
| EVAX | Evaxion Biotech A/S | 2.14 | -87.01% |
| XNCR | Xencor Inc | 2.15 | -86.95% |
| OLMA | Olema Pharmaceuticals Inc | 2.15 | -86.92% |
| TRAW | Traws Pharma Inc | 2.16 | -86.87% |
| CTNM | Contineum Therapeutics Inc - Class A | 2.18 | -86.77% |
| ABCL | AbCellera Biologics Inc | 2.19 | -86.68% |
| HRMY | Harmony Biosciences Holdings Inc | 2.21 | -86.56% |
| ZURA | Zura Bio Ltd - Class A | 2.22 | -86.55% |
| REGN | Regeneron Pharmaceuticals Inc | 2.22 | -86.54% |
| PULM | Pulmatrix Inc | 2.24 | -86.40% |
| XFOR | X4 Pharmaceuticals Inc | 2.25 | -86.33% |
| HIND | ReShape Lifesciences Inc | 2.26 | -86.29% |
| ALLO | Allogene Therapeutics Inc | 2.29 | -86.10% |
| CGEN | Compugen Ltd | 2.29 | -86.08% |
| OVID | Ovid Therapeutics Inc | 2.30 | -86.06% |
| WVE | Wave Life Sciences Ltd | 2.31 | -85.99% |
| CBIO | N/A | 2.33 | -85.85% |
| COYA | Coya Therapeutics Inc | 2.33 | -85.84% |
| GDTC | CytoMed Therapeutics Ltd | 2.39 | -85.50% |
| SKYE | Skye Bioscience Inc | 2.42 | -85.32% |
| LBRX | LB Pharmaceuticals Inc | 2.42 | -85.28% |
| IOVA | Iovance Biotherapeutics Inc | 2.43 | -85.22% |
| BNTC | Benitec Biopharma Inc | 2.43 | -85.22% |
| CYCN | Cyclerion Therapeutics Inc | 2.44 | -85.17% |
| LRMR | Larimar Therapeutics Inc | 2.45 | -85.11% |
| IMTX | Immatics N.V | 2.46 | -85.07% |
| IMNN | Imunon Inc | 2.46 | -85.04% |
| ATHE | Alterity Therapeutics Ltd | 2.46 | -85.04% |
| KYTX | Kyverna Therapeutics Inc | 2.46 | -85.04% |
| SER | AgeX Therapeutics Inc | 2.47 | -85.00% |
| PSTV | Plus Therapeutics Inc | 2.48 | -84.97% |
| CTMX | CytomX Therapeutics Inc | 2.48 | -84.94% |
| GPCR | Structure Therapeutics Inc | 2.48 | -84.92% |
| MDXG | Mimedx Group Inc | 2.50 | -84.81% |
| CRDF | Cardiff Oncology Inc | 2.50 | -84.81% |
| SRZN | Surrozen Inc | 2.50 | -84.79% |
| PTHS | Channel Therapeutics Corporation | 2.52 | -84.73% |
| PCSA | Processa Pharmaceuticals Inc | 2.53 | -84.66% |
| SLDB | Solid Biosciences Inc | 2.53 | -84.62% |
| RANI | Rani Therapeutics Holdings Inc Class A | 2.54 | -84.60% |
| ARTV | Artiva Biotherapeutics Inc | 2.54 | -84.59% |
| ORIC | ORIC Pharmaceuticals Inc | 2.63 | -84.05% |
| PALI | Palisade Bio Inc | 2.63 | -84.02% |
| NRSN | NeuroSense Therapeutics Ltd | 2.64 | -83.95% |
| ICU | SeaStar Medical Holding Corp | 2.66 | -83.85% |
| GOSS | Gossamer Bio Inc | 2.66 | -83.83% |
| NERV | Minerva Neurosciences Inc | 2.68 | -83.74% |
| BCAB | BioAtla Inc | 2.68 | -83.72% |
| ASMB | Assembly Biosciences Inc | 2.68 | -83.71% |
| CRVO | CervoMed Inc | 2.69 | -83.69% |
| PCVX | Vaxcyte Inc | 2.71 | -83.55% |
| ALLR | Allarity Therapeutics Inc | 2.71 | -83.53% |
| BEAM | Beam Therapeutics Inc | 2.73 | -83.46% |
| INMB | INmune Bio Inc | 2.74 | -83.38% |
| CRSP | CRISPR Therapeutics AG | 2.74 | -83.37% |
| ABEO | Abeona Therapeutics Inc | 2.78 | -83.15% |
| DTIL | Precision Biosciences Inc | 2.84 | -82.77% |
| TECX | AvroBio Inc | 2.85 | -82.69% |
| PLX | Protalix BioTherapeutics Inc | 2.86 | -82.61% |
| CHRS | Coherus Biosciences Inc | 2.88 | -82.49% |
| BRTX | BioRestorative Therapies Inc | 2.88 | -82.49% |
| NRXP | NRX Pharmaceuticals Inc | 2.90 | -82.37% |
| EQ | Equillium Inc | 2.92 | -82.25% |
| NTLA | Intellia Therapeutics Inc | 2.93 | -82.22% |
| CYBN | Cybin Inc | 2.94 | -82.18% |
| NCEL | NLS Pharmaceutics Ltd | 2.96 | -82.05% |
| RLMD | Relmada Therapeutics Inc | 2.97 | -81.95% |
| CGEM | Cullinan Oncology Inc | 2.98 | -81.88% |
| MLEC | Moolec Science SA | 3.00 | -81.82% |
| TBPH | Theravance Biopharma Inc | 3.01 | -81.70% |
| CGTX | Cognition Therapeutics Inc | 3.02 | -81.65% |
| XRTX | XORTX Therapeutics Inc | 3.05 | -81.51% |
| AURA | Aura Biosciences Inc | 3.06 | -81.41% |
| LEXX | Lexaria Bioscience Corp | 3.07 | -81.35% |
| LSTA | Lisata Therapeutics Inc | 3.09 | -81.23% |
| GMAB | Genmab | 3.10 | -81.15% |
| ACOG | Alpha Cognition Inc | 3.13 | -81.02% |
| MAIA | MAIA Biotechnology Inc | 3.15 | -80.85% |
| NAGE | Niagen Bioscience Inc | 3.19 | -80.62% |
| PBYI | Puma Biotechnology Inc | 3.21 | -80.53% |
| COCP | Cocrystal Pharma Inc | 3.22 | -80.48% |
| OCS | Oculis Holding AG | 3.22 | -80.45% |
| ABVC | ABVC BioPharma Inc | 3.23 | -80.37% |
| FTRE | Fortrea Holdings Inc | 3.24 | -80.31% |
| NGNE | Neoleukin Therapeutics Inc | 3.28 | -80.06% |
| JAZZ | Jazz Pharmaceuticals plc | 3.29 | -80.04% |
| ZLAB | Zai Lab Ltd | 3.29 | -80.01% |
| DRUG | Bright Minds Biosciences Inc | 3.34 | -79.71% |
| RNXT | RenovoRx Inc | 3.37 | -79.54% |
| CING | Cingulate Inc | 3.38 | -79.46% |
| ENTA | Enanta Pharmaceuticals Inc | 3.40 | -79.35% |
| CNTB | Connect Biopharma Holdings Ltd | 3.48 | -78.88% |
| ACAD | Acadia Pharmaceuticals Inc | 3.50 | -78.75% |
| PHAR | Pharming Group N.V. | 3.52 | -78.61% |
| ABUS | Arbutus Biopharma Corp | 3.54 | -78.50% |
| TENX | Tenax Therapeutics Inc | 3.54 | -78.48% |
| AUTL | Autolus Therapeutics plc | 3.55 | -78.47% |
| BCAX | Bicara Therapeutics Inc | 3.59 | -78.20% |
| MRNA | Moderna Inc | 3.61 | -78.07% |
| AUPH | Aurinia Pharmaceuticals Inc | 3.63 | -77.95% |
| RPRX | Royalty Pharma plc - Class A | 3.63 | -77.94% |
| ICCC | Immucell Corp | 3.64 | -77.91% |
| OCUL | Ocular Therapeutix Inc | 3.73 | -77.39% |
| ZVRA | Zevra Therapeutics Inc | 3.75 | -77.23% |
| IDYA | Ideaya Biosciences Inc | 3.76 | -77.15% |
| GNFT | GENFIT S.A. American Depositary Shares | 3.77 | -77.13% |
| MESO | Mesoblast Ltd | 3.77 | -77.12% |
| MLYS | Mineralys Therapeutics Inc | 3.77 | -77.11% |
| AVTX | Avalo Therapeutics Inc | 3.78 | -77.05% |
| UNCY | Unicycive Therapeutics Inc | 3.79 | -76.98% |
| GLUE | Monte Rosa Therapeutics Inc | 3.80 | -76.95% |
| CPRX | Catalyst Pharmaceuticals Inc | 3.81 | -76.90% |
| EPRX | Eupraxia Pharmaceuticals Inc | 3.82 | -76.80% |
| SPRB | Spruce Biosciences Inc | 3.85 | -76.60% |
| DSGN | Design Therapeutics Inc | 3.92 | -76.23% |
| NKTR | Nektar Therapeutics | 3.94 | -76.10% |
| DNLI | Denali Therapeutics Inc | 3.94 | -76.05% |
| GERN | Geron Corp | 3.98 | -75.86% |
| RZLT | Rezolute Inc | 3.98 | -75.83% |
| TCRT | Alaunos Therapeutics Inc | 3.98 | -75.83% |
| INCY | Incyte Corp | 4.06 | -75.36% |
| SEPN | Septerna Inc | 4.11 | -75.03% |
| ESLA | Estrella Immunopharma Inc | 4.13 | -74.91% |
| NMRA | Neumora Therapeutics Inc | 4.14 | -74.85% |
| NNVC | NanoViricides Inc | 4.14 | -74.85% |
| IRON | Disc Medicine Inc | 4.17 | -74.71% |
| CVKD | Cadrenal Therapeutics Inc | 4.17 | -74.67% |
| VRDN | Viridian Therapeutics Inc | 4.18 | -74.61% |
| CABA | Cabaletta Bio Inc | 4.20 | -74.51% |
| RAPP | Rapport Therapeutics Inc | 4.21 | -74.44% |
| KZIA | Kazia Therapeutics Ltd | 4.25 | -74.19% |
| CAPR | Capricor Therapeutics Inc | 4.28 | -74.00% |
| MPLT | MapLight Therapeutics Inc | 4.30 | -73.90% |
| IFRX | InflaRx N.V. | 4.30 | -73.87% |
| VTVT | vTv Therapeutics Inc - Class A | 4.32 | -73.75% |
| IMCR | Immunocore Holdings plc | 4.33 | -73.74% |
| IBO | Impact BioMedical Inc | 4.33 | -73.74% |
| IMNM | Immunome Inc | 4.35 | -73.62% |
| JBIO | Jade Biosciences Inc | 4.38 | -73.40% |
| GRCL | Gracell Biotechnologies Inc | 4.39 | -73.34% |
| MDWD | MediWound Ltd | 4.42 | -73.20% |
| ANRO | Alto Neuroscience Inc | 4.44 | -73.05% |
| ANNX | Annexon Inc | 4.45 | -73.01% |
| YMAB | Y-Mabs Therapeutics Inc | 4.46 | -72.93% |
| DBVT | DBV Technologies | 4.46 | -72.91% |
| ETNB | 89bio Inc | 4.49 | -72.74% |
| MIST | Milestone Pharmaceuticals Inc | 4.51 | -72.64% |
| DYN | Dyne Therapeutics Inc | 4.52 | -72.57% |
| IGC | IGC Pharma Inc | 4.57 | -72.27% |
| STOK | Stoke Therapeutics Inc | 4.59 | -72.10% |
| DNTH | Dianthus Therapeutics Inc | 4.61 | -72.03% |
| PYXS | Pyxis Oncology Inc | 4.65 | -71.77% |
| AVBP | ArriVent BioPharma Inc | 4.68 | -71.60% |
| CDXS | Codexis Inc | 4.73 | -71.28% |
| LXRX | Lexicon Pharmaceuticals Inc | 4.75 | -71.15% |
| TRML | Tourmaline Bio Inc | 4.77 | -71.06% |
| SLGL | Sol-Gel Technologies Ltd | 4.78 | -70.96% |
| AIM | AIM ImmunoTech Inc. | 4.82 | -70.74% |
| MAZE | Maze Therapeutics Inc | 4.84 | -70.61% |
| CLLS | Cellectis | 4.87 | -70.41% |
| XENE | Xenon Pharmaceuticals Inc | 4.89 | -70.28% |
| MNPR | Monopar Therapeutics Inc | 4.94 | -70.03% |
| BMEA | Biomea Fusion Inc | 4.96 | -69.87% |
| REPL | Replimune Group Inc | 4.98 | -69.74% |
| EYPT | EyePoint Pharmaceuticals Inc | 5.00 | -69.68% |
| TYRA | Tyra Biosciences Inc | 5.03 | -69.46% |
| CLYM | Eliem Therapeutics Inc | 5.12 | -68.92% |
| GANX | Gain Therapeutics Inc | 5.13 | -68.86% |
| LEGN | Legend Biotech Corp | 5.13 | -68.86% |
| CBUS | Cibus Global Ltd. Class A | 5.14 | -68.80% |
| XCUR | Exicure Inc | 5.16 | -68.67% |
| CRVS | Corvus Pharmaceuticals Inc | 5.23 | -68.25% |
| CADL | Candel Therapeutics Inc | 5.24 | -68.19% |
| TECH | Bio-Techne Corp | 5.33 | -67.64% |
| ADMA | Adma Biologics Inc | 5.33 | -67.64% |
| OBIO | Orchestra BioMed Holdings Inc | 5.37 | -67.40% |
| BYSI | BeyondSpring Inc | 5.38 | -67.34% |
| ZBIO | Zenas Biopharma Inc | 5.41 | -67.16% |
| FBRX | Forte Biosciences Inc | 5.44 | -66.97% |
| ACRS | Aclaris Therapeutics Inc | 5.44 | -66.97% |
| ROIV | Roivant Sciences Ltd | 5.55 | -66.31% |
| LCTX | Lineage Cell Therapeutics Inc | 5.65 | -65.70% |
| GNLX | Genelux Corp | 5.66 | -65.64% |
| PRQR | ProQR Therapeutics N.V | 5.70 | -65.40% |
| KLTO | Klotho Neurosciences Inc Com | 5.71 | -65.33% |
| VSTM | Verastem Inc | 5.77 | -64.97% |
| CGON | Cg Oncology Inc | 5.80 | -64.79% |
| PRLD | Prelude Therapeutics Inc | 5.81 | -64.73% |
| NAMS | NewAmsterdam Pharma Company NV | 5.85 | -64.49% |
| NRIX | Nurix Therapeutics Inc | 5.92 | -64.06% |
| GUTS | Fractyl Health Inc | 5.94 | -63.94% |
| JSPR | Jasper Therapeutics Inc | 5.95 | -63.88% |
| KYMR | Kymera Therapeutics Inc | 5.99 | -63.64% |
| VALN | Valneva SE | 6.01 | -63.51% |
| CUE | Cue Biopharma Inc | 6.11 | -62.91% |
| ALMS | Alumis Inc | 6.13 | -62.79% |
| MBX | MBX Biosciences Inc | 6.15 | -62.66% |
| EVGN | Evogene Ltd | 6.18 | -62.48% |
| NTRB | Nutriband Inc | 6.19 | -62.42% |
| VERA | Vera Therapeutics Inc - Class A | 6.20 | -62.36% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 6.21 | -62.30% |
| ACIU | AC Immune SA | 6.24 | -62.12% |
| STTK | Shattuck Labs Inc | 6.28 | -61.87% |
| CMRX | Chimerix Inc | 6.30 | -61.78% |
| XOMA | XOMA Royalty Corp | 6.30 | -61.75% |
| VRTX | Vertex Pharmaceuticals Inc | 6.30 | -61.75% |
| VANI | Vivani Medical Inc | 6.33 | -61.57% |
| VRCA | Verrica Pharmaceuticals Inc | 6.35 | -61.45% |
| MLTX | MoonLake Immunotherapeutics - Class A | 6.42 | -61.02% |
| NUVB | Nuvation Bio Inc - Class A | 6.43 | -60.96% |
| RLAY | Relay Therapeutics Inc | 6.48 | -60.66% |
| PRAX | Praxis Precision Medicines Inc | 6.48 | -60.66% |
| RNAZ | TransCode Therapeutics Inc | 6.52 | -60.42% |
| CLDX | Celldex Therapeutics Inc | 6.57 | -60.11% |
| SVRA | Savara Inc | 6.61 | -59.87% |
| HURA | TuHURA Biosciences Inc | 6.63 | -59.75% |
| HYFT | MindWalk Holdings Corp | 6.65 | -59.63% |
| SION | Sionna Therapeutics Inc | 6.66 | -59.57% |
| ONC | BeiGene Ltd | 6.68 | -59.45% |
| ADAG | Adagene Inc | 6.75 | -59.02% |
| QTTB | Q32 Bio Inc | 6.76 | -58.96% |
| RCUS | Arcus Biosciences Inc | 6.80 | -58.72% |
| VCEL | Vericel Corp | 6.81 | -58.66% |
| CRNX | Crinetics Pharmaceuticals Inc | 6.92 | -57.99% |
| GHRS | GH Research PLC | 6.98 | -57.62% |
| GYRE | Gyre Therapeutics Inc | 6.98 | -57.62% |
| ELDN | Eledon Pharmaceuticals Inc | 6.98 | -57.62% |
| CALC | CalciMedica Inc | 6.98 | -57.62% |
| TARS | Tarsus Pharmaceuticals Inc | 7.02 | -57.38% |
| EXEL | Exelixis Inc | 7.21 | -56.23% |
| ARGX | Argen X SE | 7.33 | -55.50% |
| TELO | Telomir Pharmaceuticals Inc | 7.38 | -55.20% |
| CAMP | CAMP4 Therapeutics Corp | 7.44 | -54.83% |
| ANIX | Anixa Biosciences Inc | 7.47 | -54.65% |
| BLTE | Belite Bio Inc | 7.49 | -54.53% |
| ENTX | Entera Bio Ltd | 7.52 | -54.35% |
| TSHA | Taysha Gene Therapies Inc | 7.72 | -53.13% |
| APLT | Applied Therapeutics Inc | 7.72 | -53.13% |
| ACHV | Achieve Life Sciences Inc | 7.99 | -51.49% |
| CAI | Caris Life Sciences Inc - Class A | 8.07 | -51.01% |
| APGE | Apogee Therapeutics Inc | 8.07 | -51.01% |
| APLM | Apollomics Inc - Class A | 8.12 | -50.70% |
| ELVN | Enliven Therapeutics Inc | 8.15 | -50.52% |
| PRME | Prime Medicine Inc | 8.16 | -50.46% |
| SANA | Sana Biotechnology Inc | 8.34 | -49.37% |
| NUVL | Nuvalent Inc - Class A | 8.35 | -49.31% |
| OMER | Omeros Corporation | 8.44 | -48.76% |
| KRYS | Krystal Biotech Inc | 8.45 | -48.70% |
| DMAC | DiaMedica Therapeutics Inc | 8.48 | -48.52% |
| ARDX | Ardelyx Inc | 8.58 | -47.91% |
| EWTX | Edgewise Therapeutics Inc | 8.67 | -47.37% |
| VKTX | Viking Therapeutics Inc | 8.82 | -46.45% |
| PHVS | Pharvaris NV | 8.94 | -45.73% |
| TLX | Telix Pharmaceuticals Ltd | 8.98 | -45.48% |
| IMMX | Immix Biopharma Inc | 9.01 | -45.30% |
| SLXN | Silexion Therapeutics Corp | 9.13 | -44.57% |
| AAPG | Ascentage Pharma Group International | 9.22 | -44.03% |
| PVLA | Palvella Therapeutics Inc | 9.24 | -43.90% |
| KURA | Kura Oncology Inc | 9.25 | -43.84% |
| SLN | Silence Therapeutics Plc | 9.32 | -43.42% |
| IMVT | Immunovant Inc | 9.34 | -43.30% |
| HRTX | Heron Therapeutics Inc | 9.76 | -40.75% |
| CELU | Celularity Inc - Class A | 9.89 | -39.96% |
| ABSI | Absci Corp | 10.08 | -38.81% |
| FENC | Fennec Pharmaceuticals Inc | 10.30 | -37.47% |
| ATAI | ATAI Life Sciences N.V. | 10.51 | -36.19% |
| ORKA | ARCA biopharma Inc | 10.54 | -36.01% |
| PDSB | PDS Biotechnology Corporation | 10.59 | -35.71% |
| ACTU | Actuate Therapeutics Inc | 10.87 | -34.01% |
| ZYME | Zymeworks BC Inc | 11.09 | -32.67% |
| LTRN | Lantern Pharma Inc | 11.33 | -31.22% |
| INKT | MiNK Therapeutics Inc | 11.33 | -31.22% |
| PYPD | Polypid Ltd | 11.73 | -28.79% |
| KPTI | Karyopharm Therapeutics Inc | 12.05 | -26.85% |
| COGT | Cogent Biosciences Inc | 12.13 | -26.36% |
| ATNM | Actinium Pharmaceuticals Inc | 12.19 | -26.00% |
| TNGX | Tango Therapeutics Inc | 12.33 | -25.15% |
| SPRY | ARS Pharmaceuticals Inc | 12.33 | -25.15% |
| BCDA | BioCardia Inc | 12.35 | -25.02% |
| PTGX | Protagonist Therapeutics Inc | 12.89 | -21.75% |
| SNTI | Senti Biosciences Inc | 12.99 | -21.14% |
| MGNX | Macrogenics Inc | 13.49 | -18.10% |
| OSTX | OS Therapies Inc | 13.65 | -17.13% |
| OKYO | OKYO Pharma Ltd - New | 14.11 | -14.34% |
| GOVX | Geovax Labs Inc | 14.14 | -14.16% |
| TGTX | TG Therapeutics Inc | 14.44 | -12.34% |
| CORT | Corcept Therapeutics Inc | 14.45 | -12.28% |
| TRVI | Trevi Therapeutics Inc | 14.77 | -10.33% |
| LPTX | Leap Therapeutics Inc | 14.83 | -9.99% |
| ERAS | Erasca Inc | 15.41 | -6.45% |
| NRXS | Neuraxis Inc | 15.42 | -6.39% |
| CASI | CASI Pharmaceuticals Inc | 15.65 | -4.99% |
| INO | Inovio Pharmaceuticals Inc | 15.73 | -4.50% |
| HUMA | Humacyte Inc | 15.84 | -3.84% |
| ATRA | Atara Biotherapeutics Inc | 16.14 | -2.02% |
| DRTS | Alpha Tau Medical Ltd | 16.23 | -1.47% |
| SYRE | Spyre Therapeutics Inc | 16.69 | +1.32% |
| ARWR | Arrowhead Pharmaceuticals Inc | 17.01 | +3.27% |
| BHVN | Biohaven Ltd | 17.37 | +5.45% |
| ARQT | Arcutis Biotherapeutics Inc | 17.68 | +7.33% |
| CSBR | Champions Oncology Inc | 18.84 | +14.38% |
| QURE | uniQure N.V. | 18.92 | +14.86% |
| IONS | Ionis Pharmaceuticals Inc | 19.09 | +15.89% |
| TPST | Tempest Therapeutics Inc | 19.20 | +16.56% |
| URGN | UroGen Pharma Ltd | 19.27 | +16.99% |
| IPHA | Innate Pharma | 20.10 | +22.03% |
| DYAI | Dyadic International Inc DE | 21.01 | +27.55% |
| SMMT | Summit Therapeutics Inc | 21.77 | +32.16% |
| MTSR | Metsera Inc | 21.96 | +33.32% |
| TLSA | Tiziana Life Sciences Ltd | 22.09 | +34.11% |
| MDGL | Madrigal Pharmaceuticals Inc | 22.55 | +36.90% |
| SRRK | Scholar Rock Holding Corp | 23.35 | +41.76% |
| SLS | SELLAS Life Sciences Group Inc | 23.41 | +42.12% |
| IRD | Ocuphire Pharma Inc | 23.82 | +44.61% |
| ANVS | Annovis Bio Inc | 23.95 | +45.40% |
| ABVX | Abivax | 24.03 | +45.88% |
| KOD | Kodiak Sciences Inc | 24.14 | +46.55% |
| PHAT | Phathom Pharmaceuticals Inc | 25.37 | +54.02% |
| RVMD | Revolution Medicines Inc | 26.21 | +59.12% |
| RNTX | Rein Therapeutics Inc | 28.17 | +71.02% |
| RGNX | Regenxbio Inc | 30.14 | +82.98% |
| MIRM | Mirum Pharmaceuticals Inc | 30.40 | +84.56% |
| RNAC | Cartesian Therapeutics Inc | 31.26 | +89.78% |
| ASND | Ascendis Pharma A/S | 31.35 | +90.32% |
| INSM | Insmed Inc | 33.77 | +105.02% |
| EDSA | Edesa Biotech Inc | 35.63 | +116.31% |
| ALNY | Alnylam Pharmaceuticals Inc | 35.76 | +117.10% |
| OTLK | Outlook Therapeutics Inc | 38.42 | +133.25% |
| ANL | Adlai Nortye Ltd | 38.65 | +134.66% |
| NVCT | Nuvectis Pharma Inc | 40.55 | +146.18% |
| HALO | Halozyme Therapeutics Inc | 41.10 | +149.52% |
| NVAX | Novavax Inc | 41.23 | +150.30% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 42.03 | +155.16% |
| DARE | Dare Bioscience Inc | 42.46 | +157.77% |
| EXOZ | Invizyne Technologies Inc | 42.52 | +158.14% |
| TTRX | Turn Therapeutics Inc | 46.70 | +183.51% |
| SNDX | Syndax Pharmaceuticals Inc | 51.39 | +211.99% |
| GLSI | Greenwich LifeSciences Inc | 53.00 | +221.76% |
| TVTX | Travere Therapeutics Inc | 53.75 | +226.31% |
| CYTK | Cytokinetics Inc | 60.31 | +266.14% |
| RYTM | Rhythm Pharmaceuticals Inc | 61.37 | +272.57% |
| NBTX | Nanobiotix | 65.02 | +294.73% |
| YDES | YD Bio Ltd | 66.53 | +303.90% |
| OCGN | Ocugen Inc | 83.39 | +406.25% |
| PGEN | Precigen Inc | 90.21 | +447.66% |
| PROK | ProKidney Corp - Class A | 100.75 | +511.63% |
| CELC | Celcuity Inc | 101.18 | +514.26% |
| CNSP | Cns Pharmaceuticals Inc | 106.55 | +546.86% |
| EDIT | Editas Medicine Inc | 123.59 | +650.31% |
| BBIO | BridgeBio Pharma Inc | 123.68 | +650.85% |
| ANAB | AnaptysBio Inc | 129.66 | +687.16% |
| ELTX | Elicio Therapeutics Inc | 132.74 | +705.86% |
| MNKD | Mannkind Corp | 187.85 | +1040.42% |
| GALT | Galectin Therapeutics Inc | 207.70 | +1160.93% |
| INBX | Inhibrx Biosciences Inc | 212.28 | +1188.74% |
| AGEN | Agenus Inc | 218.61 | +1227.17% |
| AXSM | Axsome Therapeutics Inc | 221.78 | +1246.41% |
| JUNS | Jupiter Neurosciences Inc | 227.66 | +1282.11% |
| MGTX | MeiraGTx Holdings plc | 228.30 | +1285.99% |
| RARE | Ultragenyx Pharmaceutical Inc | 247.70 | +1403.77% |
| INDP | Indaptus Therapeutics Inc | 277.62 | +1585.41% |
| VRNA | Verona Pharma Plc | 279.39 | +1596.17% |
| PLUR | Pluri Inc | 306.56 | +1761.10% |
| ONCY | Oncolytics Biotech Inc | 1055.04 | +6305.07% |
| PTCT | PTC Therapeutics Inc | 1743.27 | +10483.27% |
| FHTX | Foghorn Therapeutics Inc | 2005.35 | +12074.34% |